Drashtri Desai. (2017). Gefitinib Nanobubbles for Targetting EGFR-TK in Non -smell Cell Lung Cancer (NSCLC).
Cita Chicago (17th ed.)Drashtri Desai. Gefitinib Nanobubbles for Targetting EGFR-TK in Non -smell Cell Lung Cancer (NSCLC). 2017.
Cita MLA (9th ed.)Drashtri Desai. Gefitinib Nanobubbles for Targetting EGFR-TK in Non -smell Cell Lung Cancer (NSCLC). 2017.
Atenció: Aquestes cites poden no estar 100% correctes.